Product NDC: | 67253-651 |
Proprietary Name: | Propylthiouracil |
Non Proprietary Name: | Propylthiouracil |
Active Ingredient(s): | 50 mg/1 & nbsp; Propylthiouracil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67253-651 |
Labeler Name: | DAVA International Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA006188 |
Marketing Category: | NDA |
Start Marketing Date: | 20100129 |
Package NDC: | 67253-651-11 |
Package Description: | 1000 TABLET in 1 BOTTLE (67253-651-11) |
NDC Code | 67253-651-11 |
Proprietary Name | Propylthiouracil |
Package Description | 1000 TABLET in 1 BOTTLE (67253-651-11) |
Product NDC | 67253-651 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Propylthiouracil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100129 |
Marketing Category Name | NDA |
Labeler Name | DAVA International Inc. |
Substance Name | PROPYLTHIOURACIL |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |